Discovery of target based novel pyrrolyl phenoxy derivatives as antimycobacterial agents: An in silico approach

UA More, SD Joshi, TM Aminabhavi… - European journal of …, 2015 - Elsevier
A new series of pyrrolyl phenoxy derivatives bearing alkoxy linker were synthesized and
evaluated for anti-tubercular activity (anti-TB) against Mycobacterium tuberculosis …

Synthesis, biological evaluation and in silico molecular modeling of pyrrolyl benzohydrazide derivatives as enoyl ACP reductase inhibitors

SD Joshi, SR Dixit, VH Kulkarni, C Lherbet… - European Journal of …, 2017 - Elsevier
In efforts to develop lead anti-TB compounds, a novel series of 19 pyrrolyl benzohydrazides
were synthesized and screened to target enoyl-ACP reductase enzyme, which is one of the …

Synthesis and SAR evaluation of mercapto triazolobenzothiazole derivatives as anti-tuberculosis agents

M SV, SL Belagali, M Bhat - Anti-Infective Agents, 2020 - ingentaconnect.com
Background: Benzothiazoles possess a vast sphere of biological activities including anti-
inflammatory, antibacterial activities whereas triazoles display various pharmacological …

Synthesis, antimycobacterial screening and ligand-based molecular docking studies on novel pyrrole derivatives bearing pyrazoline, isoxazole and phenyl thiourea …

SD Joshi, SR Dixit, MN Kirankumar… - European journal of …, 2016 - Elsevier
We report here the synthesis, antibacterial and antitubercular evaluation of 61 novel pyrrolyl
derivatives bearing pyrazoline, isoxazole and phenyl thiourea moieties. Molecular docking …

Novel hybrid-pyrrole derivatives: their synthesis, antitubercular evaluation and docking studies

R Saha, MM Alam, M Akhter - RSC Advances, 2015 - pubs.rsc.org
Using novel hybrid molecules for the treatment of tuberculosis is one of the latest
approaches. Keeping this concept in mind, thirty two hybrid compounds were synthesized …

[PDF][PDF] Design, synthesis, characterization, and biological evaluation of some novel antitubercular agents targeting thymidylate synthetase, enoyl-ACP reductase, and l …

AJ Suresh, SG Lakshmi, VS Kumar, M Madhuraj… - J. Pharm …, 2018 - researchgate.net
Aim: Tuberculosis (TB) is the most common deadly infectious disease caused by various
strains of mycobacteria, usually Mycobacterium TB (MTB) in humans. Drugs used for TB are …

Genetic functional algorithm model, docking studies and in silico design of novel proposed compounds against Mycobacterium tuberculosis

SE Adeniji - Egyptian Journal of Basic and Applied Sciences, 2020 - Taylor & Francis
Tuberculosis still persist a major challenge to healthcare system around the world.
Increasing rates of morbidity, mortality and the reoccurrence of the resistant strains of the …

[HTML][HTML] Computational modeling and ligand-based design of some novel hypothetical compound as prominent inhibitors against Mycobacterium tuberculosis

SE Adeniji, OB Adalumo - Future Journal of Pharmaceutical Sciences, 2020 - Springer
Background Time consumed and expenses in discovering and synthesizing new
hypothetical drugs with improved biological activity have been a major challenge toward the …

Design, synthesis and computational approach to study novel pyrrole scaffolds as active inhibitors of enoyl ACP reductase (InhA) and Mycobacterium tuberculosis …

SRP Kumar, IA Shaikh, MH Mahnashi… - Journal of the Indian …, 2022 - Elsevier
Novel 54 pyrrolyl acetohydrazide analogues were designed, synthesized and screened for
antitubercular activity against InhA. Enoyl-ACP reductase/InhA one of the significant …

Identification of potent indolizine derivatives against Mycobacterial tuberculosis: In vitro anti-TB properties, in silico target validation, molecular docking and dynamics …

KN Venugopala, S Chandrashekharappa… - International Journal of …, 2024 - Elsevier
In the current study, two sets of compounds:(E)-1-(2-(4-substitutedphenyl)-2-oxoethyl)-4-
((hydroxyimino) methyl) pyridinium derivatives (3a-3e); and (E)-3-(substitutedbenzoyl)-7 …